Delivery Order SPE2DR25D3102-SPE2DR26F2P7P
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes, valued at $48,775.58 with a firm fixed price structure. The award, issued on November 26, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of November 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, valued at $5,119.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $13,188.24. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $5,364.04 and is scheduled for completion by December 11, 2025. The award is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,066.71 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract, designated as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) under a firm fixed-price contract with a ceiling value of $2,325.06. The delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation and was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $3,582.05. The contract is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized in this competitive award. This delivery order operates...
- The Defense Logistics Agency awarded a $39,915.00 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Boostrix TDAP vaccine syringes (0.5mL). This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents performance at the contractor's Conshohocken, Pennsylvania facility. The award was not designated as a set-aside contract and was competitively awarded to the prime contractor. This delivery order is issued under...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P7PDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $1,415.04. This is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Boostrix TDAP vaccine delivery supports the Defense Health Agency and other federal military healthcare systems' immunization requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/16/25 |